SEC Form 4 · accession 0001209191-17-056099
BioAmber Inc. · BIOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard P Eno
Officer — Chief Executive Officer · Director
Period of report
Oct 2, 2017
Accepted (ET)
Oct 5, 2017 · 2:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001534287
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.48 | Oct 2, 2017 | A | 500,000 | A | — | Aug 16, 2027 | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1All options granted vest on a monthly basis over a period of 36 months following the grant date, October 2, 2017